[TNM classification of bone and soft tissue sarcomas]

Area of Science:

• Orthopedic Oncology
• Cancer Research
• Biostatistics

Context:

• The TNM classification system for bone and soft tissue sarcomas, established by UICC in 1987, has limitations in clarity and prognostic utility for osteosarcoma.
• Histological grading (G) criteria within the UICC TNM system are not well-defined, and lymph node metastasis is infrequent, limiting prognostic factors.
• The existing UICC TNM classification has shown a lack of correlation with survival rates in osteosarcoma patients, hindering its widespread adoption in orthopedic oncology.

Purpose:

• To introduce and evaluate a modified TNM classification system for osteosarcoma developed by the Japanese Orthopaedic Association's Musculoskeletal Tumor Committee.
• To improve the prognostic accuracy of staging for osteosarcoma by incorporating key clinical and pathological factors.
• To establish a clearer correlation between cancer stage and patient survival rates in osteosarcoma.

Summary:

• A modified TNM classification for osteosarcoma was developed, incorporating tumor size (T1 <15 cm, T2 ≥15 cm), UICC N and M criteria, serum alkaline phosphatase levels (A0 <2.5x normal, A1 ≥2.5x normal), and histological grade (G1 0-9/HPF, G2 ≥10/HPF).
• This revised system, based on multivariate analysis, reclassifies osteosarcoma cases.
• Reclassification using the modified TNM system demonstrated a significant correlation between the determined stage and patient survival rates.

Impact:

• The proposed TNM classification offers a more accurate prognostic tool for osteosarcoma compared to the previous UICC system.
• This improved staging system can aid in treatment planning and patient management in orthopedic oncology.
• The findings support the wider adoption of this modified TNM system for osteosarcoma staging and research.